Similar articles

• Guidelines for the diagnosis and treatment of chronic inflammatory demyelinating polyneuropathy.

  Berger AR, Bradley WG, Brannagan TH, Busis NA, Cros DP, Dalakas MC, Danon MJ, Donofrio P, Engel WK, England JD, Feldman EL, Freeman RL, Kinsella LJ, Lacomis D, Latov N, Menkes DL, Sander HW, Thomas FP, Triggs WJ, Windebank AJ, Wolfe GI; Neuropathy Association, Medical Advisory Committee. Berger AR, et al. J Peripher Nerv Syst. 2003 Dec;8(4):282-4. J Peripher Nerv Syst. 2003. PMID: 14641652 No abstract available.
• Comment on European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy.

  Latov N. Latov N. J Peripher Nerv Syst. 2006 Mar;11(1):88-9; author reply 90-1. doi: 10.1111/j.1085-9489.2006.00068.x. J Peripher Nerv Syst. 2006. PMID: 16519787 No abstract available.
• Predicting treatment response in chronic, acquired demyelinating neuropathies.

  Chan YC, Wilder-Smith E. Chan YC, et al. Expert Rev Neurother. 2006 Oct;6(10):1545-53. doi: 10.1586/14737175.6.10.1545. Expert Rev Neurother. 2006. PMID: 17078793 Review.
• [Review of guideline on new diagnostic criteria for chronic inflammatory demyelinating polyneuropathy].

  Odaka M. Odaka M. No To Shinkei. 2006 Sep;58(9):771-7. No To Shinkei. 2006. PMID: 17052004 Review. Japanese. No abstract available.
• [Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)].

  Nakamura S. Nakamura S. Ryoikibetsu Shokogun Shirizu. 2000;(31):52-5. Ryoikibetsu Shokogun Shirizu. 2000. PMID: 11269152 Review. Japanese. No abstract available.